Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  113 results for ""Angiotensin II Type 1 Receptor Blockers""

Your Filters

Publisher : mosby
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Rationale and design of the PRAETORIAN-COVID trial: A double-blind, placebo-controlled randomized clinical trial with valsartan for PRevention of Acute rEspiraTORy dIstress syndrome in hospitAlized patieNts with SARS-COV-2 Infection Disease.

Subjects: Betacoronavirus* ; Coronary Care Units* ; Randomized Controlled Trials as Topic*

  • Source: American heart journal [Am Heart J] 2020 Aug; Vol. 226, pp. 60-68. Date of Electronic Publication: 2020 May 21.Publisher: Mosby Country of Publication: United States NLM ID: 0370465 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

The association of chronic kidney disease with the use of renin-angiotensin system inhibitors after acute myocardial infarction.

  • Authors : Wetmore JB; Division of Nephrology, Hennepin County Medical Center, Minneapolis, MN; Chronic Disease Research Group, Hennepin County Medical Center, Minneapolis, MN. Electronic address: .

Subjects: Registries*; Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*adverse effects ; Angiotensin-Converting Enzyme Inhibitors/Angiotensin-Converting Enzyme Inhibitors/Angiotensin-Converting Enzyme Inhibitors/*adverse effects

  • Source: American heart journal [Am Heart J] 2015 Oct; Vol. 170 (4), pp. 735-43. Date of Electronic Publication: 2015 Jul 26.Publisher: Mosby Country of Publication: United States NLM ID: 0370465 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Rationale and design: the VALsartan In Diastolic Dysfunction (VALIDD) Trial: evolving the management of diastolic dysfunction in hypertension.

Subjects: Research Design*; Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*pharmacology ; Diastole/Diastole/Diastole/*drug effects

  • Source: American heart journal [Am Heart J] 2006 Aug; Vol. 152 (2), pp. 246-52.Publisher: Mosby Country of Publication: United States NLM ID: 0370465 Publication Model: Print Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: a meta-analysis.

  • Authors : Balamuthusamy S; Division of Nephrology, Department of Medicine, Rosalind Franklin University/Chicago Medical School, Chicago, IL 60064, USA. ; Srinivasan L

Subjects: Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*pharmacology ; Angiotensin-Converting Enzyme Inhibitors/Angiotensin-Converting Enzyme Inhibitors/Angiotensin-Converting Enzyme Inhibitors/*pharmacology ; Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/*prevention & control

  • Source: American heart journal [Am Heart J] 2008 May; Vol. 155 (5), pp. 791-805.Publisher: Mosby Country of Publication: United States NLM ID: 0370465 Publication Model: Print Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

What is the role of angiotensin-receptor blockade in cardiovascular protection?

  • Authors : Cohn JN; Cardiovascular Division, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.

Subjects: Angiotensin Receptor Antagonists*; Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*pharmacology ; Angiotensin-Converting Enzyme Inhibitors/Angiotensin-Converting Enzyme Inhibitors/Angiotensin-Converting Enzyme Inhibitors/*pharmacology

  • Source: American heart journal [Am Heart J] 2006 Nov; Vol. 152 (5), pp. 859.e1-8.Publisher: Mosby Country of Publication: United States NLM ID: 0370465 Publication Model: Print Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

A double-blind, randomized, placebo-controlled multicenter clinical trial to evaluate the effects of the angiotensin II receptor blocker candesartan cilexetil on intimal hyperplasia after coronary stent implantation.

Subjects: Stents*/Stents*/Stents*/adverse effects; Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*therapeutic use ; Benzimidazoles/Benzimidazoles/Benzimidazoles/*therapeutic use

  • Source: American heart journal [Am Heart J] 2006 Oct; Vol. 152 (4), pp. 761.e1-6.Publisher: Mosby Country of Publication: United States NLM ID: 0370465 Publication Model: Print Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program.

Subjects: Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*therapeutic use ; Atrial Fibrillation/Atrial Fibrillation/Atrial Fibrillation/*prevention & control ; Benzimidazoles/Benzimidazoles/Benzimidazoles/*therapeutic use

  • Source: American heart journal [Am Heart J] 2006 Jul; Vol. 152 (1), pp. 86-92.Publisher: Mosby Country of Publication: United States NLM ID: 0370465 Publication Model: Print Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial.

Subjects: Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*therapeutic use ; Angiotensin-Converting Enzyme Inhibitors/Angiotensin-Converting Enzyme Inhibitors/Angiotensin-Converting Enzyme Inhibitors/*administration & dosage ; Benzimidazoles/Benzimidazoles/Benzimidazoles/*therapeutic use

  • Source: American heart journal [Am Heart J] 2006 May; Vol. 151 (5), pp. 985-91.Publisher: Mosby Country of Publication: United States NLM ID: 0370465 Publication Model: Print Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

The angiotensin II receptor blocker candesartan cilexetil reduces neointima proliferation after coronary stent implantation: a prospective randomized study under intravascular ultrasound guidance.

  • Authors : Yoshida O; Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan. ; Hirayama H

Subjects: Stents*; Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*therapeutic use ; Benzimidazoles/Benzimidazoles/Benzimidazoles/*therapeutic use

  • Source: American heart journal [Am Heart J] 2005 Jan; Vol. 149 (1), pp. e2.Publisher: Mosby Country of Publication: United States NLM ID: 0370465 Publication Model: Print Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Morbidity, mortality, physiologic and functional parameters in elderly and non-elderly patients in the Valsartan Heart Failure Trial (Val-HeFT).

Subjects: Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*therapeutic use ; Heart Failure/Heart Failure/Heart Failure/*drug therapy ; Tetrazoles/Tetrazoles/Tetrazoles/*therapeutic use

  • Source: American heart journal [Am Heart J] 2004 Dec; Vol. 148 (6), pp. 951-7.Publisher: Mosby Country of Publication: United States NLM ID: 0370465 Publication Model: Print Cited Medium: Internet

Record details

Read More Add to Saved list
×
  • 1-10 of  113 results for ""Angiotensin II Type 1 Receptor Blockers""